Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | CTH | P32929 | 1/20 | 0.43 |
| ▸ | CBS | P35520 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TPI1 | P60174 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10476512 | 0.84 | TSHR (0.36) | TSHRCTHCBSTHPOTHRB | |
| Phosphoglycolic Acid SCHEMBL380471 | 0.79 | — | — | |
| SCHEMBL8852887 | 0.79 | MVD (0.42) | TSHRCTHCBSTHPOTHRB | |
| Phosphoglycolic Acid SCHEMBL20798069 | 0.79 | TPI1 (0.54) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL2984826 | 0.78 | SMN1; SMN2 (0.32) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL20712038 | 0.77 | TSHR (0.58) | TSHRLMNAKMT2ATDP1ALDH1A1 | |
| Phosphoglycolic Acid SCHEMBL5586781 | 0.77 | TPI1 (0.52) | TSHRCTHCBSTHPOTHRB | |
| Phosphoglycolic Acid SCHEMBL29156120 | 0.77 | TPI1 (0.52) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL13022683 | 0.77 | — | — | |
| Phosphoglycolic Acid SCHEMBL27790872 | 0.77 | TSHR (0.39) | TSHRCTHCBSTHPOTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116077642-A | Compositions and methods for reducing or preventing metastasis | 高级健康研究所 | 2023-05-09 | — | — | CN | disclosed |
| CN-109310773-B | Formulations containing TLR agonists and methods of use | 传染病研究所 | 2022-04-26 | — | — | CN | disclosed |
| CN-107540730-B | Vaccines for HSV-2 | 免疫设计公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-107540730-A | Vaccine for HSV 2 | 免疫设计公司 | 2018-01-05 | — | — | CN | disclosed |
| CN-104412108-B | Vaccines for HSV-2 | 免疫设计公司 | 2017-08-25 | — | — | CN | disclosed |
| US-9480740-B2 | Synthetic glucopyranosyl lipid adjuvants | INFECTIOUS DISEASE RESEARCH INSTITUTE (US) | 2016-11-01 | — | — | US | disclosed |
| US-20140322268-A1 | SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS | INFECTIOUS DISEASE RESEARCH INSTITUTE (US) | 2014-10-30 | — | — | US | disclosed |
| CN-102965959-B | Wool refining treating fluid and treating method | UNIV TIANJIN POLYTECHNIC | 2014-05-28 | — | — | CN | disclosed |
| CN-102965959-A | Wool refining treating fluid and treating method | UNIV TIANJIN POLYTECHNIC | 2013-03-13 | — | — | CN | disclosed |
| US-20100310602-A1 | SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS | INFECTIOUS DISEASE RESEARCH INSTITUTE (US) | 2010-12-09 | — | — | US | disclosed |
| US-5384241-A | Specific binding assay compound with inhibitive self-quenching characteristics | ENZO DIAGNOSTICS, INC. (US) | 1995-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140322268-A1 | SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS | B3GAT3, GLA, LGALS8 | TSHR 1791/4885CTH 4361/4885CBS 4489/4885 |
| US-20100310602-A1 | SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS | B3GAT3, GLA, LGALS8 | TSHR 1791/4885CTH 4361/4885CBS 4489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.